Patient-specific signaling signatures predict optimal therapeutic combinations for triple negative breast cancer
Heba Alkhatib, Jason Conage-Pough, Sangita Roy Chowdhury, Denen Shian, Deema Zaid, Ariel M. Rubinstein, Amir Sonnenblick, Tamar Peretz-Yablonsky, Avital Granit, Einat Carmon, Ishwar N. Kohale, Judy C. Boughey, Matthew P. Goetz, Liewei Wang, Forest M. White*, Nataly Kravchenko-Balasha*
Research output: Contribution to journal › Letter › peer-review
4Scopus
citations
Fingerprint
Dive into the research topics of 'Patient-specific signaling signatures predict optimal therapeutic combinations for triple negative breast cancer'. Together they form a unique fingerprint.